Mohammad-Ali Shahbazi
Overview
Explore the profile of Mohammad-Ali Shahbazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
1782
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin Y, Wang N, Hu B, Guo J, Chen Q, Chen Z, et al.
J Colloid Interface Sci
. 2025 Feb;
686:634-649.
PMID: 39914308
Inorganic nanoparticles serve as versatile nanoplatforms for efficient cancer diagnosis and therapy. However, their limited in vivo degradability and excretion rates may lead to various adverse effects. Furthermore, the cascade-controlled...
2.
Pedrinha V, Barros M, Portes J, Slomp A, Woudstra W, Lameira O, et al.
Biomed Pharmacother
. 2025 Jan;
183:117833.
PMID: 39827810
Researching disinfection strategies is pivotal because effectively eliminating bacteria and their byproducts during root canal treatment (RCT) remains a challenge. This study investigated the antimicrobial efficacy of natural antimicrobial compounds,...
3.
Xu H, Wang Y, Liu G, Zhu Z, Shahbazi M, Reis R, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(7):e2410011.
PMID: 39739630
Despite being a groundbreaking approach to treating colorectal cancer (CRC), the efficacy of immunotherapy is significantly compromised by the immunosuppressive tumor microenvironment and dysbiotic intestinal microbiota. Here, leveraging the superior...
4.
Han H, Wang S, Shahbazi M, Zuhorn I, Cai Z, Chen J, et al.
J Control Release
. 2024 Dec;
378:350-364.
PMID: 39701450
ROS-induced therapy can eradicate breast tumors when combined with thermal ablation, but excessive ROS also threatens peritumoral tissue with inflammation. To eradicate tumors and avoid inflammatory sequela, it is necessary...
5.
Han H, Wang S, Shahbazi M, Du Y, Zuhorn I, Li J, et al.
J Control Release
. 2024 Dec;
378:320-333.
PMID: 39689815
Anti-glycolysis is well-recognized for inhibition of tumor proliferation. However, tumor metabolic heterogeneity confers great challenges in the therapeutic efficacy of glycolysis inhibitors. Here, a metabolic trapping strategy was employed to...
6.
Mahmoudi N, Sharifi S, Leshchiner D, Horibata S, Lin Z, Ghazali N, et al.
Br J Dermatol
. 2024 Nov;
192(3):390-401.
PMID: 39565404
Chronic wounds, defined by their prolonged healing process, significantly impair patients' quality of life and impose a hefty financial burden on healthcare systems worldwide. Sex- and gender-specific mechanisms regulate inflammation...
7.
Pouyanfar N, Farnam G, Ahmadi M, Masoudifar R, Banan K, Asadian E, et al.
Int J Biol Macromol
. 2024 Nov;
283(Pt 2):137715.
PMID: 39551326
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the joints, leading to pain, swelling, and potential joint destruction. Effective management of RA is crucial to improve...
8.
Asadian E, Abbaszadeh S, Ghorbani-Bidkorpeh F, Rezaei S, Xiao B, Santos H, et al.
Biomater Sci
. 2024 Nov;
13(1):9-92.
PMID: 39534968
The field of biomedical engineering continually seeks innovative technologies to address complex healthcare challenges, ranging from tissue regeneration to drug delivery and biosensing. Plant skeletons offer promising opportunities for these...
9.
Chen B, Ting He Y, Zhao Z, Feng Y, Liang L, Peng J, et al.
Adv Drug Deliv Rev
. 2024 Nov;
:115109.
PMID: 39492421
The remarkable appeal of microneedle controlled-release systems has captivated both the academic community and pharmaceutical industry due to their great potential for achieving spatiotemporally controlled release, coupled with their the...
10.
Xiong Y, Mi B, Shahbazi M, Xia T, Xiao J
Mil Med Res
. 2024 Oct;
11(1):69.
PMID: 39434177
Severe tissue defects present formidable challenges to human health, persisting as major contributors to mortality rates. The complex pathological microenvironment, particularly the disrupted immune landscape within these defects, poses substantial...